Heterocyclic ether substituted imidazoquinolines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 16, 2003
Grant Date -
Apr 3, 2003
app pub date -
Dec 6, 2001
filing date -
Dec 8, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and heterocyclyl or heteroaryl functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully